Lippman has been appointed associate vice chancellor for cancer research and care in transition from director of Moores Cancer Center and will lead ambitious Atlas effort
The California Institute for Regenerative Medicine (CIRM) approved a $4.1 million grant to enable University of California San Diego School of Medicine researchers to advance a new chimeric antigen receptor (CAR) T-cell therapy from the laboratory into the clinic.
Susanna Soon-Chun Park was inducted as the inaugural holder of the Barbara A. and Alan M. Roth, M.D. Endowed Chair for Discovery, Education and Patient Care during a special ceremony at the SMUD Museum of Science and Curiosity.
UC Davis Comprehensive Cancer Center becomes the first in Northern California to start a program that is bringing new hope to patients whose colon cancer has spread to their liver. One of the first patients to undergo the unique procedure in July is now cancer-free.
A new paper published in The New England Journal of Medicine suggests that secondary antibodies known as “anti-idiotype antibodies” could be responsible for some of the side effects of COVID-19 vaccines and the symptoms of long-haul COVID.
